ARCHIVES

Cancer Groups Criticize FDA For Ignoring Expert Advice.

This article is from The Cancer Letter archive.

Vol. 26 No. 43 | November 24, 2000

Download PDF Visit The Full Archive

Related Articles

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

In Brief: Senate Committee Confirms Varmus; Albertini Directs Vermont Cancer Center

November 19, 1993

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008